CN109562124A - 用于处理肌腱退化的方法和组合物 - Google Patents

用于处理肌腱退化的方法和组合物 Download PDF

Info

Publication number
CN109562124A
CN109562124A CN201780039455.6A CN201780039455A CN109562124A CN 109562124 A CN109562124 A CN 109562124A CN 201780039455 A CN201780039455 A CN 201780039455A CN 109562124 A CN109562124 A CN 109562124A
Authority
CN
China
Prior art keywords
composition
tendon
carbohydrate
composition according
injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780039455.6A
Other languages
English (en)
Chinese (zh)
Inventor
C·D·怀特
E·S·安
S·D·诺尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anika Therapeutics Inc
Original Assignee
Anika Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anika Therapeutics Inc filed Critical Anika Therapeutics Inc
Publication of CN109562124A publication Critical patent/CN109562124A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/386—Ligaments, tendons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/10—Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Details Of Rigid Or Semi-Rigid Containers (AREA)
CN201780039455.6A 2016-04-27 2017-04-26 用于处理肌腱退化的方法和组合物 Pending CN109562124A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662328396P 2016-04-27 2016-04-27
US62/328,396 2016-04-27
US201662367377P 2016-07-27 2016-07-27
US62/367,377 2016-07-27
PCT/US2017/029635 WO2017189723A1 (en) 2016-04-27 2017-04-26 Compositions for use in treating tendon degeneration

Publications (1)

Publication Number Publication Date
CN109562124A true CN109562124A (zh) 2019-04-02

Family

ID=58709560

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780039455.6A Pending CN109562124A (zh) 2016-04-27 2017-04-26 用于处理肌腱退化的方法和组合物

Country Status (15)

Country Link
US (1) US10441677B2 (https=)
EP (1) EP3448394B1 (https=)
JP (1) JP6826657B2 (https=)
KR (1) KR20190009303A (https=)
CN (1) CN109562124A (https=)
AU (1) AU2017257956B2 (https=)
CA (1) CA3021764C (https=)
IL (1) IL262507B (https=)
MX (1) MX375382B (https=)
NZ (1) NZ747413A (https=)
RU (1) RU2018141386A (https=)
SG (2) SG11201809197XA (https=)
TW (2) TW202114712A (https=)
WO (1) WO2017189723A1 (https=)
ZA (1) ZA201807136B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3735204B1 (en) 2018-01-02 2023-09-06 Cartiheal (2009) Ltd. Implantation tool for optimized solid substrates promoting cell and tissue growth
JP2024006681A (ja) * 2022-07-04 2024-01-17 学校法人近畿大学 生体材料
KR102940883B1 (ko) * 2022-12-27 2026-03-17 차의과학대학교 산학협력단 비타민 d를 포함하는 건병증 또는 근육손상 치료용 히알루론산 하이드로겔계 약물 전달 시스템 및 이의 제조방법
WO2025096427A1 (en) * 2023-10-29 2025-05-08 Brown David Donaldson Methods for treating lower back pain with hyaluronic acid

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1859918A (zh) * 2003-10-09 2006-11-08 罗伯特·约翰·佩特雷拉 使用透明质酸治疗急性和过劳扭伤、拉伤的方法
CN102665412A (zh) * 2009-09-23 2012-09-12 克能药物有限公司 用于诱导或加强结缔组织修复的组合物和方法
CN104703612A (zh) * 2012-09-26 2015-06-10 骨治疗公司 包含溶剂/去污剂处理过的血浆(s/d血浆)的制剂及其用途

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2946819A (en) 1958-04-14 1960-07-26 Gen Aniline & Film Corp Process of producing carbodimides
DE1156401B (de) 1960-05-24 1963-10-31 Bayer Ag Verfahren zur Herstellung von Carbodiimiden
DE1149712B (de) 1961-11-14 1963-06-06 Bayer Ag Verfahren zur Herstellung von Carbodiimiden
US3644456A (en) 1964-08-12 1972-02-22 Upjohn Co Di((isocyanatobenzyl)-phenyl) carbodiimides and preparation of organic carbodiimides
US3972933A (en) 1974-05-28 1976-08-03 Monsanto Company Preparation of carbodiimides from ureas by dehydration
GB1476088A (en) 1975-04-03 1977-06-10 Ici Ltd Carbodiimides
DE2556760A1 (de) 1975-12-17 1977-06-30 Hoechst Ag Verfahren zur herstellung von carbodiimiden
GB1584153A (en) 1976-09-22 1981-02-04 Ici Ltd Carbodimides
US4066629A (en) 1976-10-28 1978-01-03 Celanese Corporation Process for preparing carbodiimides utilizing a phosphonium salt catalyst
US4098973A (en) 1977-01-31 1978-07-04 The Upjohn Company Compounds and process
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5356883A (en) 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
ITPD940054A1 (it) 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
DK0971961T3 (da) 1997-04-04 2003-03-24 Fidia Advanced Biopolymers Srl N-sulfaterede hyaluronsyreforbindelser, derivater deraf og en fremgangsmåde til deres fremstilling
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
ATE243049T1 (de) 1999-12-09 2003-07-15 Biosyntech Canada Inc Mineral-polymer hybrid-zusammensetzung
CA2416126C (en) 2000-07-28 2011-07-05 Anika Therapeutics, Inc. Bioabsorbable composites of derivatized hyaluronic acid
IT1317358B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Derivati cross-linkati dell'acido ialuronico.
IT1317359B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e
ATE312076T1 (de) 2001-02-22 2005-12-15 Anika Therapeutics Inc Thiol-modifizierte hyaluronan-derivate
US20060272221A1 (en) 2001-11-29 2006-12-07 Treibacher Schleifmittel Gmbh Al2O3 and ZrO2 based abrasive grain, method for the production and use thereof
JP4489437B2 (ja) 2002-02-21 2010-06-23 エンセル，インコーポレイテッド 表面コーティングとしての固定化生物活性ヒドロゲルマトリックス
ITPD20020064A1 (it) 2002-03-12 2003-09-12 Fidia Advanced Biopolymers Srl Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem
DE60305036T2 (de) 2002-06-19 2006-10-12 Dr. H.C. Robert Mathys Stiftung Hydraulischer zement auf basis von calciumphosphat für chirurgische anwendungen
US8455458B2 (en) 2002-10-16 2013-06-04 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage
DE10257554B4 (de) 2002-12-10 2008-04-10 Treibacher Schleifmittel Gmbh Schleifkörner mit einer Ummantelung aus einem wässrigen Bindemittel und einer komplexen feinkörnigen Oxidverbindung, Verfahren zur Behandlung derartiger Schleifkörner sowie ihre Verwendung für kunstharzgebundene Schleifmittel
US8124120B2 (en) 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
WO2007070547A2 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
EP1891984A1 (en) 2006-08-24 2008-02-27 Graftys Macroporous and highly resorbable apatitic calcium-phosphate cement
IT1393419B1 (it) 2009-03-19 2012-04-20 Medivis S R L Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
BR112012020566B1 (pt) * 2010-02-22 2021-09-21 Biomimetic Therapeutics, Llc Composição de fator de crescimento derivado de plaqueta
CN103841927A (zh) 2011-06-09 2014-06-04 齐默尔膝部创造物公司 用于软骨下关节修复的器械和装置
MX368000B (es) 2012-03-22 2019-09-13 Trb Chemedica Int S A Composición de colágeno y ácido hialurónico para la reparación de ligamento o tendón.
EP3107590B1 (en) * 2014-02-20 2021-11-17 Ortho Regenerative Technologies Inc. Freeze-dried polymer compositions for mixing with platelet rich plasma to form implants for tissue repair and/or compositions for therapeutic intra-articular injections

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1859918A (zh) * 2003-10-09 2006-11-08 罗伯特·约翰·佩特雷拉 使用透明质酸治疗急性和过劳扭伤、拉伤的方法
CN102665412A (zh) * 2009-09-23 2012-09-12 克能药物有限公司 用于诱导或加强结缔组织修复的组合物和方法
CN104703612A (zh) * 2012-09-26 2015-06-10 骨治疗公司 包含溶剂/去污剂处理过的血浆(s/d血浆)的制剂及其用途

Also Published As

Publication number Publication date
CA3021764C (en) 2021-01-19
ZA201807136B (en) 2021-05-26
TW201739457A (zh) 2017-11-16
IL262507B (en) 2020-10-29
MX375382B (es) 2025-03-06
EP3448394C0 (en) 2023-09-13
TWI755392B (zh) 2022-02-21
US10441677B2 (en) 2019-10-15
SG10201913342UA (en) 2020-03-30
AU2017257956B2 (en) 2019-11-07
US20170326271A1 (en) 2017-11-16
JP2019516784A (ja) 2019-06-20
TW202114712A (zh) 2021-04-16
RU2018141386A (ru) 2020-05-27
CA3021764A1 (en) 2017-11-02
NZ747413A (en) 2020-09-25
EP3448394B1 (en) 2023-09-13
WO2017189723A1 (en) 2017-11-02
IL262507A (en) 2018-12-31
JP6826657B2 (ja) 2021-02-03
SG11201809197XA (en) 2018-11-29
KR20190009303A (ko) 2019-01-28
MX2018012964A (es) 2019-06-10
EP3448394A1 (en) 2019-03-06
RU2018141386A3 (https=) 2020-05-27
AU2017257956A1 (en) 2018-11-15
WO2017189723A9 (en) 2018-06-28

Similar Documents

Publication Publication Date Title
Duranti et al. Injectable hyaluronic acid gel for soft tissue augmentation: A clinical and histological study
JP7025039B2 (ja) 高い弾性を有するヒアルロナンの組成物およびその使用
WO2010049898A1 (en) Injectable polydeoxyribonucleotide composition for the treatment of osteoarticular diseases
CN109562124A (zh) 用于处理肌腱退化的方法和组合物
Gwinner et al. Two-staged application of PRP in arthroscopic rotator cuff repair: a matched-pair analysis
US20260115253A1 (en) Viscous composition for treating ischemia
Tinsley et al. Platelet-rich plasma nonoperative injection therapy—a review of indications and evidence
US7371399B2 (en) Polymer gel containing hyaluronic acid and collagen, and its use in joints
JP2012521270A (ja) 軟骨修復
CN111194220B (zh) 用于治疗缺血的肝素组合物
HK40006859A (en) Compositions for use in treating tendon degeneration
HK40005732B (en) Compositions for use in treating tendon degeneration
HK40005732A (en) Compositions for use in treating tendon degeneration

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40006859

Country of ref document: HK

RJ01 Rejection of invention patent application after publication

Application publication date: 20190402

RJ01 Rejection of invention patent application after publication